Literature DB >> 19396494

Surgical treatment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Evans et al.

Reid B Adams1, Peter J Allen.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19396494     DOI: 10.1245/s10434-009-0410-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  5 in total

1.  Prognostic Value of Metastatic Lymph Node Ratio in Pancreatic Cancer.

Authors:  Can A Karaca; Ahmet Coker
Journal:  Indian J Surg Oncol       Date:  2018-10-26

Review 2.  Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.

Authors:  Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

3.  Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth.

Authors:  Chen Huang; Guang Yang; Tao Jiang; Jun Cao; Ke-Jian Huang; Zheng-Jun Qiu
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

4.  Sentinel lymph node mapping in tumors of the pancreatic body: preliminary report.

Authors:  Adam Durczyński; Piotr Hogendorf; Dariusz Szymański; Piotr Grzelak; Janusz Strzelczyk
Journal:  Contemp Oncol (Pozn)       Date:  2012-07-06

5.  TWELVE YEARS OF EXPERIENCE USING CHOLECYSTOJEJUNAL BY-PASS FOR PALLIATIVE TREATMENT OF ADVANCED PANCREATIC CANCER.

Authors:  Marcos Belotto de Oliveira; Bruna do Nascimento Santos; André de Moricz; Adhemar Monteiro Pacheco-Junior; Rodrigo Altenfelder Silva; Renata D'Alpino Peixoto; Tércio De Campos
Journal:  Arq Bras Cir Dig       Date:  2017 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.